Skip to main content

Long-term survival from the initial trial of bevacizumab and irinotecan.

Publication ,  Journal Article
Desjardins, A; Vredenburgh, JJ; Reardon, DA; Herndon, JE; Marcello, J; Peters, K; Gururangan, S; Sathornsumetee, S; Rich, JN; Friedman, HS
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2010

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15

Publisher

AMER SOC CLINICAL ONCOLOGY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Vredenburgh, J. J., Reardon, D. A., Herndon, J. E., Marcello, J., Peters, K., … Friedman, H. S. (2010). Long-term survival from the initial trial of bevacizumab and irinotecan. JOURNAL OF CLINICAL ONCOLOGY, 28(15).
Desjardins, A., J. J. Vredenburgh, D. A. Reardon, J. E. Herndon, J. Marcello, K. Peters, S. Gururangan, S. Sathornsumetee, J. N. Rich, and H. S. Friedman. “Long-term survival from the initial trial of bevacizumab and irinotecan.JOURNAL OF CLINICAL ONCOLOGY 28, no. 15 (May 20, 2010).
Desjardins A, Vredenburgh JJ, Reardon DA, Herndon JE, Marcello J, Peters K, et al. Long-term survival from the initial trial of bevacizumab and irinotecan. JOURNAL OF CLINICAL ONCOLOGY. 2010 May 20;28(15).
Desjardins, A., et al. “Long-term survival from the initial trial of bevacizumab and irinotecan.JOURNAL OF CLINICAL ONCOLOGY, vol. 28, no. 15, AMER SOC CLINICAL ONCOLOGY, May 2010.
Desjardins A, Vredenburgh JJ, Reardon DA, Herndon JE, Marcello J, Peters K, Gururangan S, Sathornsumetee S, Rich JN, Friedman HS. Long-term survival from the initial trial of bevacizumab and irinotecan. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2010 May 20;28(15).

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15

Publisher

AMER SOC CLINICAL ONCOLOGY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences